Evolving profile of severe and critical COVID-19 according: Cases admitted to the University Hospital of Kinshasa (UHK) = the official name of the institution from March 24, 2020 to December 12, 2022

Author:

Sonzi Donatien Mangala1,Risassi Jean-Robert Makulo1,Ndona Madone Mandina1,Mambimbi Marcel Mbula1,Mashi Murielle Longokolo1,Bepouka Ben1,Ossam Odio1,Kayembe Harry César1,Kaswangala Béni Béni1,Kapour Germain1,Ngongo Nadine Mayasi2,Lusunsi Christian Kisoka1,Tuna Lukiana1,Bompangue Didier1,Situakibanza Hippolyte Nani-Tuma1

Affiliation:

1. University of Kinshasa

2. Cliniques Universitaires de Kinshasa

Abstract

Abstract Background: Severe and critical forms of COVID-19 require early conventional oxygen therapy. Objective: The aim of this study was to analyze the evolution of Severe and critical COVID-19 patients treated at the University Hospital of Kinshasa according to News score. Methods: This was a historical cohort study carried out at the COVID-19 Treatment Center (of the University Hospital of Kinshasa (UHK) from March 24, 2020 to December 12, 2022. The target population was all patients (1159) admitted to the intensive care unit of the COVID-19 Treatment Center of the UHK. All tests were two-tailed with 95% CI and considered significant when P-value was < 0.05. Results: Of a total of 1159 patients, severe and critical forms accounted for 84.2% (n=976), with the age category of patients over 60 years the most represented at 52.2% (n=605), with a mean age of 58.1±17.3 years. Severe and critical patients with at least one comorbidity 74.2% (n=724) were admitted to CTCO CUK and 84.6% (n=981) of these patients required respiratory support with conventional oxygen therapy. Factors predictive of lethality were the use of CPAP and mechanical ventilation with HRa (95% CI) of 0.001 and 0.002 respectively, age> 60 years and late referral to UHK. Conclusion: Ultimately, this study showed that severe COVID-19 patients require early and effective management.

Publisher

Research Square Platform LLC

Reference28 articles.

1. Salzberger B, Buder F, Lampl B, Ehrenstein B, Hitzenbichler F, Holzmann T et al. Epidemiology of SARS-CoV-2. Infection 2021;49:233–9.

2. 40894-doc-AfricaCDC_COVIDBrief_21Sep21_FR.pdf.

3. Coronavirus disease 2019 (COVID-19) epidemic in the Democratic Republic of Congo - Weekly situation report No. 11/2023 of 03/19/2023 | Data collected 03/13/2023 to 03/19/2023 - Democratic Republic of the Congo | ReliefWeb. 2023. https://reliefweb.int/report/democratic-republic-congo/epidemie-de-la-disease-coronavirus-2019-covid-19-en-republique-democratique-du-congo-rapport-de-situation- hebdo-ndeg-112023-from-19032023-data-collected-13032023-to-19032023. Accessed 17 Apr 2023.

4. Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study;Alharthy A;J Epidemiol Glob Health,2021

5. WHO-AF-ARD. -DAK-05-2020-eng.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3